• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NGM
    5.71 Down 0.41(6.70%) Jun 24, 4:00PM EDT
    |After Hours : 5.71 0.00 (0.00%) Jun 24, 5:23PM EDT
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Net Income (147,957) (83,291) (130,925)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation4,288  3,223  2,589  
    Adjustments To Net Income23,572  22,566  14,051  
    Changes In Accounts Receivables(3,170)2,587  3,410  
    Changes In Liabilities19,934  18,836  8,315  
    Changes In Inventories(3,717) -   -  
    Changes In Other Operating Activities1,524  1,539  7,145  
    Total Cash Flow From Operating Activities (105,356) (34,808) (95,175)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(12,789)(6,035)(9,857)
    Investments87,899  26  (17,823)
    Other Cash flows from Investing Activities -  (2)(59)
    Total Cash Flows From Investing Activities 75,110   (6,011) (27,739)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -  (7)(3)
    Sale Purchase of Stock50,730  10,384  28,752  
    Net Borrowings129,434  1,044  121,537  
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 180,164   11,421   150,286  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 149,918   (29,398) 27,372  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.